Clinical trial
A Text Messaging (SMS) Intervention to Improve Adherence to Stimulant Medications in Children With ADHD
NCT04189562 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Text Messaging (SMS) Intervention to Improve Adherence to Stimulant Medications in Children With ADHD
- Lead sponsor
- Massachusetts General Hospital
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- February 22, 2017
- Completion date
- June 30, 2023
- Enrollment
- 300 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
attention deficit/hyperactivity disorder